Sisram Medical Crescita futura
Future criteri di controllo 4/6
Si prevede che Sisram Medical aumenterà i profitti e i ricavi rispettivamente del 26.8% e 13.4% all'anno.
Informazioni chiave
26.8%
Tasso di crescita degli utili
n/a
Tasso di crescita dell'EPS
| Medical Equipment crescita degli utili | 40.1% |
| Tasso di crescita dei ricavi | 13.4% |
| Rendimento futuro del capitale proprio | n/a |
| Copertura analitica | Low |
| Ultimo aggiornamento | 15 Nov 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
What Sisram Medical Ltd's (HKG:1696) 40% Share Price Gain Is Not Telling You
Oct 07
Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Aug 23Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet
Jul 24Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)
Jun 17Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Apr 21Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?
Mar 28Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Mar 05Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)
Jan 23Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?
Dec 29Is Sisram Medical (HKG:1696) Using Too Much Debt?
Nov 09Returns On Capital At Sisram Medical (HKG:1696) Have Stalled
Oct 19At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?
Sep 18Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year
Aug 14Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?
Jun 16Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue
May 30Is Sisram Medical (HKG:1696) Using Too Much Debt?
Apr 19Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?
Mar 01Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital
Jan 12Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet
Dec 21Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?
Dec 01Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital
Oct 14Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching
Sep 28These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
Aug 25Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?
Aug 01These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely
May 19Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?
May 03If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late
Apr 11Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital
Mar 17Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?
Nov 22Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)
Aug 22Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital
Jul 27Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair
Jun 24Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2026 | 495 | 48 | N/A | N/A | 1 |
| 12/31/2025 | 438 | 41 | N/A | 18 | 2 |
| 12/31/2024 | 379 | 32 | N/A | 17 | 2 |
| 6/30/2024 | 356 | 24 | 33 | 40 | N/A |
| 3/31/2024 | 358 | 28 | 34 | 42 | N/A |
| 12/31/2023 | 359 | 31 | 35 | 44 | N/A |
| 9/30/2023 | 355 | 35 | -5 | 32 | N/A |
| 6/30/2023 | 352 | 38 | -46 | 19 | N/A |
| 3/31/2023 | 353 | 39 | -44 | 21 | N/A |
| 12/31/2022 | 354 | 40 | -42 | 22 | N/A |
| 9/30/2022 | 349 | 38 | -11 | 22 | N/A |
| 6/30/2022 | 344 | 35 | 19 | 22 | N/A |
| 3/31/2022 | 319 | 33 | 24 | 27 | N/A |
| 12/31/2021 | 294 | 31 | 29 | 32 | N/A |
| 9/30/2021 | 255 | 28 | 35 | 40 | N/A |
| 6/30/2021 | 216 | 24 | 42 | 47 | N/A |
| 3/31/2021 | 189 | 19 | 29 | 36 | N/A |
| 12/31/2020 | 162 | 13 | 16 | 26 | N/A |
| 9/30/2020 | 161 | 13 | 10 | 19 | N/A |
| 6/30/2020 | 160 | 13 | 4 | 12 | N/A |
| 3/31/2020 | 167 | 17 | 11 | 17 | N/A |
| 12/31/2019 | 174 | 21 | 18 | 21 | N/A |
| 9/30/2019 | 167 | 22 | 19 | 21 | N/A |
| 6/30/2019 | 161 | 24 | 19 | 22 | N/A |
| 3/31/2019 | 158 | 23 | 17 | 19 | N/A |
| 12/31/2018 | 154 | 22 | 15 | 16 | N/A |
| 9/30/2018 | 151 | 18 | 13 | 14 | N/A |
| 6/30/2018 | 149 | 14 | 10 | 11 | N/A |
| 3/31/2018 | 143 | 12 | N/A | 14 | N/A |
| 12/31/2017 | 137 | 11 | N/A | 17 | N/A |
| 9/30/2017 | 131 | 11 | N/A | 18 | N/A |
| 6/30/2017 | 126 | 10 | N/A | 19 | N/A |
| 3/31/2017 | 123 | 11 | N/A | 20 | N/A |
| 12/31/2016 | 118 | 8 | N/A | 16 | N/A |
| 12/31/2015 | 110 | 8 | N/A | 16 | N/A |
| 12/31/2014 | 101 | 6 | N/A | 23 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: La crescita prevista degli utili di 1696 ( 26.8% all'anno) è superiore al tasso di risparmio ( 2.3% ).
Guadagni vs Mercato: Si prevede che gli utili di 1696 ( 26.8% all'anno) cresceranno più rapidamente del mercato Hong Kong ( 11.7% all'anno).
Guadagni ad alta crescita: Si prevede che gli utili di 1696 cresceranno in modo significativo nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di 1696 ( 13.4% all'anno) crescerà più rapidamente del mercato Hong Kong ( 7.8% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di 1696 ( 13.4% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Dati insufficienti per determinare se il Return on Equity di 1696 è previsto essere elevato tra 3 anni